3Screen™ - Assay development services based on cleared-tissue image analysis
Customized assay endpoints based on tissue clearing.
Let us help you get the most out of your tissues.
With our extensive portfolio of over 50 High Content Screening assays enhanced by tissue clearing, we are able to tailor any assay to meet your needs.
Microtissue DILI screening
Evaluate drug induced liver injury in microtissue models
Blood vessel network analysis
Leveraging our expertise in whole-mount immunolabeling, we can convert any traditional cell-based assay, microtissue assay, or IHC endpoint into a high-content imaging workflow.
Tired of slides? We employ whole-mount immunolabeling and tissue clearing to convert IHC to HCS.
- Antibody penetration
- Cell-cell junctions and cadherins
- Cell proliferation
- Cell migration
- Cell viability
- Drug induced liver injury
- Immune cell invasion
- Inflammatory Signaling
- Mitochondrial Health + Toxicity
- Neuronal Differentiation
- Neuronal Function